New York Life Investment Management LLC Ligand Pharmaceuticals Inc Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$68.64 - $89.2 $31,848 - $41,388	464 Added 9.81%	5,195 $379,000
Q4 2023 Feb 05, 2024	SELL	$49.57 - $72.63 $5,452 - $7,989	-110 Reduced 2.27%	4,731 $337,000
Q3 2023 Nov 07, 2023	SELL	$58.86 - $72.67 $44,792 - $55,301	-761 Reduced 13.58%	4,841 $290,000
Q2 2023 Aug 04, 2023	SELL	$69.53 - $79.33 $65,983 - $75,284	-949 Reduced 14.49%	5,602 $403,000
Q1 2023 May 08, 2023	BUY	$65.67 - $77.08 $430,204 - $504,951	6,551 New	6,551 $481,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.